The Mammatech Corporation (OTCBB:MAMH) announced today that it anticipates a 20 to 1 reverse split in the company's shares of common stock effective 22 November 2004. The Company's Form 8-K stated that it intends to seek financing for new product development. H.S. Pennypacker, Ph.D., President of Mammatech, said "the company is developing computer assisted tactile trainer that will help produce and verify high levels of clinical breast examination (CBE) skill." Dr. Mark K. Goldstein, Mammatech's Chairman, reported that published studies continue to find that most breast cancers are first detected by someone's hands. The Company's MammaCare(R) program is the recognized standard for proficient CBE(1) MammaCare as developed by Mammatech scientists with grant support from the National Cancer Institute.
